Serum S100A8/S100A9 is associated with increased risk of brain metastasis in patients with inflammatory breast cancer. - Villodre ES; Song J; Hu X; Gomez K; Cohen EN; Reuben JM; Nasrazadani A; Lim B; Tripathy D; Woodward WA; Krishnamurthy S; Debeb BG (MedRxiv : the preprint server for health sciences, 2026)